Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
real estate
Biotech
‘It’s just survival’: Why a third of Boston lab space sits empty
Vacancy rates for lab and manufacturing space in Massachusetts increased 11-fold to 31% between 2021 and 2026. So what's gone wrong?
Will Maddox
Oct 8, 2026 8:00am
Takeda consolidates Boston footprint
Feb 11, 2026 3:51pm
Lab demand shrinks in life sciences real estate market
Sep 19, 2023 1:49pm
GSK grabs Boston lab space as part of RNA drive
Jan 12, 2023 9:05am
The top biotech hubs in 2022
Jul 5, 2022 3:00am
Insurer plans $4B lab space blitz outside of U.S. hot spots
May 25, 2022 8:25am
